Overview

Reduced Opioid Analgesic Requirements Via Improved Endogenous Opioid Function

Status:
Completed
Trial end date:
2019-09-01
Target enrollment:
Participant gender:
Summary
Chronic Pain (CP) management has increasingly utilized long-term opioid analgesic therapy, a change associated with increased opioid abuse (via greater exposure in vulnerable individuals), non-pain health consequences (hormone changes, falls), and a dramatic rise in opioid-related overdoses and deaths. Treatment strategies that minimize the need for chronic high-dose opioids are sorely needed. This project will test the novel hypothesis that effective pain relief can be achieved at lower opioid analgesic doses by increasing levels of endogenous opioids (EOs).
Phase:
N/A
Details
Lead Sponsor:
Vanderbilt University Medical Center
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Analgesics
Analgesics, Opioid
Endorphins
Morphine
Naloxone